See What HealthDay Can Do For You
Contact Us

Many Flavored E-Cigarettes Contain Benzaldehyde

Highest levels in cherry-flavored e-cigarettes; levels >1,000-fold lower than those in workplace

e-cigarette

FRIDAY, Jan. 29, 2016 (HealthDay News) -- Most flavored electronic cigarettes contain benzaldehyde, which has been shown to cause irritation of the respiratory airways in animal and occupational exposure studies, according to a research letter published online Jan. 28 in Thorax.

Leon Kosmider, from the Institute of Occupational Medicine and Environmental Health in Sosnowiec, Poland, and colleagues measured benzaldehyde in aerosol generated in a laboratory setting from flavored e-cigarettes.

The researchers detected benzaldehyde in 108 out of 145 products, with the highest levels detected in cherry-flavored products. The benzaldehyde dose inhaled with 30 puffs was frequently higher from flavored versus conventional cigarettes. The estimated median daily inhaled dose of benzaldehyde from cherry-flavored e-cigarettes was 70.3 µg, which was more than 1,000 times lower than doses inhaled in the workplace.

"While e-cigarettes seem to be a promising harm reduction tool for smokers, findings indicate that using these products could result in repeated inhalation of benzaldehyde, with long-term users risking regular exposure to the substance," the authors write. "Given the uncertainty surrounding adverse health effects stemming from long-term inhalation of flavoring ingredients such as benzaldehyde, clinicians need to be aware of this emerging risk and ask their patients about use of flavored e-cigarettes."

Two authors disclosed financial ties to companies that manufacture electronic cigarettes.

Abstract
Full Text

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.